Dr Lucy NorlingSenior Lecturer, Versus Arthritis Senior FellowCentre: Biochemical Pharmacology Email: l.v.norling@qmul.ac.ukTelephone: +44(0) 20 7882 5644ProfileResearchPublicationsSponsorsCollaboratorsNewsProfileORCID iD: 0000-0001-5316-9115 Lucy Norling graduated with a Masters in Research and PhD from the William Harvey Research Institute, Queen Mary University of London in 2008. Her research focused on galectin-1; an endogenous regulator of inflammatory resolution. Dr. Norling was then awarded a 3 year Arthritis Research UK Foundation Fellowship to study the generation and bioactions of novel lipid mediators derived from omega-3 fatty acids and spent two years training at Harvard Medical School, Boston, with the mentorship of Professor Charles Serhan. In 2012 Dr Norling attained a 5 year Arthritis Research UK Career Development Fellowship to investigate the protective actions of omega-3 fatty acid derived specialized pro-resolving lipid mediators (SPM) in inflammatory arthritis. SPM provide a molecular mechanism for the beneficial effects of fish oil supplementation in patients with arthritis, and offer novel therapeutic approaches to treat inflammatory diseases. In 2019 Dr Norling was awarded a 5 year Versus Arthritis Senior Fellowship entitled “Reprogramming Resolution in the Arthritic Joint”. Her current research aims to determine whether inflammatory joint diseases persist due to an inadequate synthesis of SPM and explores how SPM protect and repair joint tissue.ResearchGroup members Hannah Law, Silvia Oggero, Shani Austin-Williams, Chiara Cecconello, Michele Padaovan. Summary Our understanding of how the inflammatory process is terminated has evolved, with the appreciation that protective mediators actively resolve inflammation. The discovery of omega-3 fatty acid derived specialized pro-resolving lipid mediators (SPM) provides a molecular mechanism for the beneficial effects of fish oil supplementation in patients with arthritis, and offer novel therapeutic approaches to treat inflammatory diseases. Supported by my Foundation Fellowship, I demonstrated that SPM inhibit PMN-endothelial interactions, dampen acute inflammation, and help fight infection. During my Career Development Fellowship I investigated the bioactions of SPM in experimental arthritis and found that resolvin D1 limits joint leukocyte infiltration, arthritis severity and protected from cartilage damage. We also determined that production of specific SPM including resolvin D3 is dysregulated in experimental arthritis, and that local SPM within murine joints can be modulated by omega-3 dietary supplementation. There is a clear need to develop new innovative therapeutic agents for arthritis that can both reduce the inflammation that drives disease AND initiate tissue repair and regeneration. With the support of a Versus Arthritis Senior Fellowship I aim to establish how SPM reprogram innate immune cells and stromal cells within the joint tissue to switch on repair mechanisms that temper the aggressive and inappropriate behaviour of cells within the joint tissue to ultimately protect the cartilage from erosion. The overarching goal of our research is to establish novel leads for the restoration of joint function to ultimately limit disability and improve the lives of patients with arthritis.Publications Thomas BL, Montero‐Melendez T, Oggero S et al. (2024). Molecular Determinants of Neutrophil Extracellular Vesicles That Drive Cartilage Regeneration in Inflammatory Arthritis. nameOfConference DOI: 10.1002/art.42958 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/98715 Hussain MT, Austin-Williams S, Wright TD et al. (publicationYear). β1-Integrin-Mediated Uptake of Chondrocyte Extracellular Vesicles Regulates Chondrocyte Homeostasis. nameOfConference DOI: 10.3390/ijms25094756 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/97635 Norling LV, Cooper D (2023). Being old and female is an inflammatory combination. nameOfConference DOI: 10.1093/jleuko/qiad077 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/95403 Chen J, Austin-Williams S, O'Riordan CE et al. (2023). Formyl Peptide Receptor Type 2 Deficiency in Myeloid Cells Amplifies Sepsis-Induced Cardiac Dysfunction. nameOfConference DOI: 10.1159/000530284 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/85560 Norling LV, Headland SE, Dalli J et al. (2023). Proresolving and cartilage-protective actions of resolvin D1 in inflammatory arthritis. nameOfConference DOI: 10.1172/jci.insight.168728 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/88868 Norling LV, Halade GV (2022). Helpful inflammation turned harmful in non-communicable diseases. nameOfConference DOI: 10.1016/j.coph.2022.102317 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/83342 Qin CX, Norling LV, Vecchio EA et al. (2022). Formylpeptide receptor 2: Nomenclature, structure, signalling and translational perspectives: IUPHAR review 35. nameOfConference DOI: 10.1111/bph.15919 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/82714 Oggero S, Godec T, van Gorp R et al. (2022). Role of plasma extracellular vesicles in prediction of cardiovascular risk and alterations in response to statin therapy in hypertensive patients. nameOfConference DOI: 10.1097/hjh.0000000000003178 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/79497 Cecconello C, Ribas PC, Norling LV (2022). Chapter 4 Resolving acute inflammation; what happens when inflammation goes haywire? How can it get back in line?. nameOfConference DOI: 10.1016/b978-0-12-822130-3.00018-1 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/85555 Iqbal AJ, Krautter F, Blacksell IA et al. (2022). Galectin‐9 mediates neutrophil capture and adhesion in a CD44 and β2 integrin‐dependent manner. nameOfConference DOI: 10.1096/fj.202100832r QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/76220 Chen J, Norling LV, Mesa JG et al. (2021). Annexin A1 attenuates cardiac diastolic dysfunction in mice with inflammatory arthritis. nameOfConference DOI: 10.1073/pnas.2020385118 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/74989 Austin-Williams S, Hussain MT, Oggero S et al. (2021). Enhancing Extracellular Vesicles for therapeutic treatment of arthritic joints. nameOfConference DOI: 10.1016/j.freeradbiomed.2021.08.235 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/83340 Oggero S, de Gaetano M, Marcone S et al. (2021). Extracellular vesicles from monocyte/platelet aggregates modulate human atherosclerotic plaque reactivity. nameOfConference DOI: 10.1002/jev2.12084 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/72444 Chen J, Norling LV, Cooper D (publicationYear). Cardiac Dysfunction in Rheumatoid Arthritis: The Role of Inflammation. nameOfConference DOI: 10.3390/cells10040881 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/76222 Brouwers H, Jónasdóttir HS, Kuipers ME et al. (2020). Anti-Inflammatory and Proresolving Effects of the Omega-6 Polyunsaturated Fatty Acid Adrenic Acid.. nameOfConference DOI: 10.4049/jimmunol.1801653 QMRO: qmroHref Souza PR, Walker ME, Goulding NJ et al. (2020). The GPR40 Agonist GW9508 Enhances Neutrophil Function to Aid Bacterial Clearance During E. coli Infections. nameOfConference DOI: 10.3389/fimmu.2020.573019 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/67519 Hussain MT, Iqbal AJ, Norling LV (publicationYear). The Role and Impact of Extracellular Vesicles in the Modulation and Delivery of Cytokines during Autoimmunity. nameOfConference DOI: 10.3390/ijms21197096 QMRO: qmroHref Oggero S, Norling L, Perretti M (2018). Microvesicles in cardiovascular inflammation: markers or mediators of cardiovascular diseases?. nameOfConference DOI: 10.1254/jpssuppl.wcp2018.0_po1-2-71 QMRO: qmroHref Norling LV, Perretti M (2020). Proresolving lipid mediators enhance PMN-mediated bacterial clearance. nameOfConference DOI: 10.1073/pnas.2004241117 QMRO: qmroHref Norling L, Cooper D, Law H et al. (2020). A pro-resolving role for Galectin-1 in acute inflammation. nameOfConference DOI: 10.3389/fphar.2020.00274 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/64197 Topping LM, Thomas BL, Rhys HI et al. (2020). Targeting Extracellular Vesicles to the Arthritic Joint Using a Damaged Cartilage-Specific Antibody. nameOfConference DOI: 10.3389/fimmu.2020.00010 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/63161 Padovan MG, Norling LV (2020). Pro-resolving lipid mediators in sepsis and critical illness. nameOfConference DOI: 10.1097/mco.0000000000000633 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/62319 Oggero S, Austin-Williams S, Norling LV (2019). The contrasting role of extracellular vesicles in vascular inflammation and tissue repair. nameOfConference DOI: 10.3389/fphar.2019.01479 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/62780 Oggero S, Van Gorp R, Cooper D et al. (2019). Monocyte and not Neutrophil derived microvesicles are able to activate endothelial cells and smooth muscle cells and to enhance recruitment of PMN in a Flow Chamber based assay. nameOfConference DOI: doi QMRO: qmroHref Oggero S, Van Gorp R, Norling LV et al. (2019). Stimulation of monocyte-platelet aggregation drives formation of microvesicle subsets to promote vascular inflammation. nameOfConference DOI: doi QMRO: qmroHref Topping LM, Vinci C, Rhys H et al. (2018). OP0260 Targeting neutrophil microvesicles to damaged cartilage using antibodies to post-translationally modified collagen ii. FRIDAY, 15 JUNE 2018 DOI: 10.1136/annrheumdis-2018-eular.6744 QMRO: qmroHref Thomas BL, Jones HR, Norling LV et al. (2018). Neutrophil extracellular vesicles have a cartilage protective effect during inflammatory arthritis. nameOfConference DOI: 10.1016/j.joca.2018.02.273 QMRO: qmroHref Rhys HI, Dell'Accio F, Pitzalis C et al. (2018). Neutrophil Microvesicles from Healthy Control and Rheumatoid Arthritis Patients Prevent the Inflammatory Activation of Macrophages. nameOfConference DOI: 10.1016/j.ebiom.2018.02.003 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/36528 Topping L, Rhys H, Norling L et al. (2017). FRI0011 Targeting neutrophil microvesicles to damaged cartilage using antibodies to post translationally modified collagen ii. Poster Presentations DOI: 10.1136/annrheumdis-2017-eular.4842 QMRO: qmroHref Perretti M, Norling LV (2017). Actions of SPM in regulating host responses in arthritis. nameOfConference DOI: 10.1016/j.mam.2017.04.005 QMRO: qmroHref Piovezan AP, Batisti AP, Benevides MLACS et al. (2017). Hydroalcoholic crude extract of Casearia sylvestris Sw. reduces chronic post-ischemic pain by activation of pro-resolving pathways. nameOfConference DOI: 10.1016/j.jep.2017.03.059 QMRO: qmroHref Norling LV, Ly L, Dalli J (2017). Resolving inflammation by using nutrition therapy: roles for specialized proresolving mediators.. nameOfConference DOI: 10.1097/MCO.0000000000000353 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/18759 Perretti M, Cooper D, Dalli J et al. (2017). Immune resolution mechanisms in inflammatory arthritis.. nameOfConference DOI: 10.1038/nrrheum.2016.193 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/18889 Souza PR, Jones HR, Norling LV (2017). Novel immunoregulatory mediators produced from omega-3 fatty acids. nameOfConference DOI: 10.1201/9781315118901 QMRO: qmroHref Wright RD, Souza PR, Flak MB et al. (publicationYear). Galectin-3-null mice display defective neutrophil clearance during acute inflammation.. nameOfConference DOI: 10.1189/jlb.3A0116-026RR QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/18859 Ross EA, Naylor AJ, O'Neil JD et al. (2017). Treatment of inflammatory arthritis via targeting of tristetraprolin, a master regulator of pro-inflammatory gene expression. nameOfConference DOI: 10.1136/annrheumdis-2016-209424 QMRO: qmroHref Arnardottir HH, Dalli J, Norling LV et al. (2016). Resolvin D3 Is Dysregulated in Arthritis and Reduces Arthritic Inflammation.. nameOfConference DOI: 10.4049/jimmunol.1502268 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/23490 Souza PR, Norling LV (2016). Implications for eicosapentaenoic acid- and docosahexaenoic acid-derived resolvins as therapeutics for arthritis. nameOfConference DOI: 10.1016/j.ejphar.2015.05.072 QMRO: qmroHref Norling L, Headland S, Dalli J et al. (2016). PRO-RESOLVING AND CARTILAGE-PROTECTIVE ACTIONS OF RESOLVIN D1 IN INFLAMMATORY ARTHRITIS. EULAR DOI: 10.1136/annrheumdis-2016-eular.6116 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/24545 Norling LV, Headland SE, Dalli J et al. (2016). Proresolving and cartilage-protective actions of resolvin D1 in inflammatory arthritis. nameOfConference DOI: 10.1172/jci.insight.85922 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/12017 Headland SE, Jones HR, Norling LV et al. (2015). Neutrophil-derived microvesicles enter cartilage and protect the joint in inflammatory arthritis. nameOfConference DOI: 10.1126/scitranslmed.aac5608 QMRO: qmroHref Canova DF, Pavlov AM, Norling LV et al. (2015). Alpha-2-macroglobulin loaded microcapsules enhance human leukocyte functions and innate immune response. nameOfConference DOI: 10.1016/j.jconrel.2015.09.021 QMRO: qmroHref Headland SE, Norling LV (2015). The resolution of inflammation: Principles and challenges. nameOfConference DOI: 10.1016/j.smim.2015.03.014 QMRO: qmroHref Headland S, Norling L, Kim A et al. (2015). Neutrophil‐Derived Microvesicles Migrate into Cell‐Impenetrable Cartilage to Protect the Joint During Inflammatory Arthritis. nameOfConference DOI: 10.1096/fasebj.29.1_supplement.285.11 QMRO: qmroHref Ross E, Smallie T, Naylor A et al. (2015). A8.1 Tristetraprolin is a novel therapeutic target for rheumatoid arthritis. nameOfConference DOI: 10.1136/annrheumdis-2015-207259.186 QMRO: qmroHref Burgmaier M, Schutters K, Willems B et al. (2014). AnxA5 reduces plaque inflammation of advanced atherosclerotic lesions in apoE−/− mice. nameOfConference DOI: 10.1111/jcmm.12374 QMRO: qmroHref Montero-Melendez T, Madeira MFM, Norling LV et al. (2014). Association between periodontal disease and inflammatory arthritis reveals modulatory functions by melanocortin receptor type 3.. nameOfConference DOI: 10.1016/j.ajpath.2014.04.009 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/43046 Cash JL, Norling LV, Perretti M (2014). Resolution of inflammation: targeting GPCRs that interact with lipids and peptides.. nameOfConference DOI: 10.1016/j.drudis.2014.06.023 QMRO: qmroHref Headland SE, Jones HR, D'Sa ASV et al. (2014). Cutting-edge analysis of extracellular microparticles using ImageStream(X) imaging flow cytometry.. nameOfConference DOI: 10.1038/srep05237 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/10076 Ayoub SS, Norling LV, Leoni G et al. (2010). Cell Adhesion Molecules. nameOfConference DOI: 10.1017/cbo9781139195737.018 QMRO: qmroHref Headland S, Norling L, Patel H et al. (2014). A novel mechanism for protecting the arthritic joint: microparticles deliver Annexin A1 into cartilage (146.8). nameOfConference DOI: 10.1096/fasebj.28.1_supplement.146.8 QMRO: qmroHref Norling L, Headland S, Dalli J et al. (2014). Resolvin D1 protects from neutrophil mediated joint destruction in inflammatory arthritis (146.5). nameOfConference DOI: 10.1096/fasebj.28.1_supplement.146.5 QMRO: qmroHref Dalli J, Norling LV, Montero-Melendez T et al. (2014). Microparticle alpha-2-macroglobulin enhances pro-resolving responses and promotes survival in sepsis.. nameOfConference DOI: 10.1002/emmm.201303503 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/10756 Dalli J, Montero-Melendez T, Norling LV et al. (2013). Heterogeneity in neutrophil microparticles reveals distinct proteome and functional properties.. nameOfConference DOI: 10.1074/mcp.M113.028589 QMRO: qmroHref Norling LV, Dalli J (2013). Microparticles are novel effectors of immunity.. nameOfConference DOI: 10.1016/j.coph.2013.05.008 QMRO: qmroHref Norling LV, Perretti M (2013). The role of omega-3 derived resolvins in arthritis.. nameOfConference DOI: 10.1016/j.coph.2013.02.003 QMRO: qmroHref Norling LV, Perretti M (2013). Control of myeloid cell trafficking in resolution.. nameOfConference DOI: 10.1159/000350612 QMRO: qmroHref Perretti M, Dalli J, Norling LV et al. (2013). Neutrophil Microparticles are heterogenous in content and function. nameOfConference DOI: 10.1096/fasebj.27.1_supplement.138.5 QMRO: qmroHref Norling LV, Perretti M (2013). Omega-3 derived Resolvin D1 reduces the severity of inflammatory arthritis. nameOfConference DOI: 10.1096/fasebj.27.1_supplement.649.1 QMRO: qmroHref Yazid S, Norling LV, Flower RJ (2012). Anti-inflammatory drugs, eicosanoids and the annexin A1/FPR2 anti-inflammatory system.. nameOfConference DOI: 10.1016/j.prostaglandins.2011.11.005 QMRO: qmroHref Norling LV, Dalli J, Flower RJ et al. (2012). Resolvin D1 limits polymorphonuclear leukocyte recruitment to inflammatory loci: receptor-dependent actions.. nameOfConference DOI: 10.1161/ATVBAHA.112.249508 QMRO: qmroHref Gil-Villa AM, Norling LV, Serhan CN et al. (2012). Aspirin triggered-lipoxin A4 reduces the adhesion of human polymorphonuclear neutrophils to endothelial cells initiated by preeclamptic plasma.. nameOfConference DOI: 10.1016/j.plefa.2012.08.003 QMRO: qmroHref Norling L, Dalli J, Flower R et al. (2012). RESOLVIN D1 LIMITS PMN RECRUITMENT TO INFLAMMATORY LOCI: RECEPTOR DEPENDENT BIOACTIONS. nameOfConference DOI: doi QMRO: qmroHref Norling LV, Dalli J, Flower RJ et al. (2012). Resolvin D1 limits PMN recruitment to inflammatory loci: receptor dependent bioactions. nameOfConference DOI: 10.1096/fasebj.26.1_supplement.835.17 QMRO: qmroHref Norling LV, Dalli J, Serhan CN et al. (2011). RESOLVIN D1 LIMITS PMN RECRUITMENT TO INFLAMMATORY LOCI: RECEPTOR DEPENDENT BIOACTIONS. nameOfConference DOI: doi QMRO: qmroHref Norling LV, Spite M, Yang R et al. (2011). Cutting Edge: Humanized Nano-Proresolving Medicines Mimic Inflammation-Resolution and Enhance Wound Healing. nameOfConference DOI: 10.4049/jimmunol.1003865 QMRO: qmroHref Norling LV, Spite M, Yang R et al. (2011). Cutting edge: Humanized nano-proresolving medicines mimic inflammation-resolution and enhance wound healing.. nameOfConference DOI: 10.4049/jimmunol.1003865 QMRO: qmroHref Canaider S, Vettraino M, Norling LV et al. (2010). Human RCAN3 gene expression and cell growth in endothelial cells. nameOfConference DOI: 10.3892/ijmm_00000542 QMRO: qmroHref Canaider S, Vettraino M, Norling LV et al. (2010). Human RCAN3 gene expression and cell growth in endothelial cells.. nameOfConference DOI: 10.3892/ijmm_00000542 QMRO: qmroHref Norling LV, Serhan CN (2010). Profiling in resolving inflammatory exudates identifies novel anti-inflammatory and pro-resolving mediators and signals for termination.. nameOfConference DOI: 10.1111/j.1365-2796.2010.02235.x QMRO: qmroHref Norling LV, Dalli J, Flower RJ et al. (2010). Resolvin D1 limits PMN recruitment to inflammatory loci: receptor dependent bioactions. nameOfConference DOI: doi QMRO: qmroHref Canaider S, Vettraino M, Norling LV et al. (2010). Human RCAN3 gene expression and cell growth in endothelial cells. nameOfConference DOI: 10.3892/ijmm_00000542 QMRO: qmroHref Spite M, Norling LV, Summers L et al. (2009). Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis.. nameOfConference DOI: 10.1038/nature08541 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/19168 Piqueras L, Sanz MJ, Perretti M et al. (2009). Activation of PPAR beta/delta inhibits leukocyte recruitment, cell adhesion molecule expression, and chemokine release. nameOfConference DOI: 10.1189/JLB.0508284 QMRO: qmroHref Norling LV, Perretti M, Cooper D (2009). Endogenous galectins and the control of the host inflammatory response.. nameOfConference DOI: 10.1677/JOE-08-0512 QMRO: qmroHref Dalli J, Norling LV, Renshaw D et al. (2008). Annexin 1 mediates the rapid anti-inflammatory effects of neutrophil-derived microparticles. nameOfConference DOI: 10.1182/blood-2008-02-140533 QMRO: qmroHref Cooper D, Norling LV, Perretti M (2008). Novel insights into the inhibitory effects of Galectin-1 on neutrophil recruitment under flow.. nameOfConference DOI: 10.1189/jlb.1207831 QMRO: qmroHref Dasgupta B, Dalli J, Norling L et al. (2008). Altered expression of annexin 1 and its receptor in neutrophils of patients with giant cell arteritis (GCA) and ANCA associated vasculitis (AAV). nameOfConference DOI: doi QMRO: qmroHref Norling LV, Sampaio ALF, Cooper D et al. (2008). Inhibitory control of endothelial galectin-1 on in vitro and in vivo lymphocyte trafficking. nameOfConference DOI: 10.1096/fj.07-9268com QMRO: qmroHref Harrington LS, Evans RJ, Wray J et al. (2007). Purinergic 2X(1) receptors mediate endothelial dependent vasodilation to ATP. nameOfConference DOI: 10.1124/mol.107.037325 QMRO: qmroHref Norling LV, Cooper D, Perretti M (2006). Endogenous Galectn-1 inhibits lymphocyte-endothelial cell interactions as determined by small interference RNA. nameOfConference DOI: 10.1096/fasebj.20.4.a647-a QMRO: qmroHref Sponsors Versus Arthritis Barts Charity European Union’s Horizon 2020 research and innovation Marie Curie Actions Versus Arthritis OA Centre for Pathogenesis Centre for Inflammation & Therapeutic Innovation CollaboratorsInternal Prof. Jesmond Dalli (QMUL) Dr. Tina Chowdury (QMUL) External Prof. Charles Serhan, Brigham & Women’s Hospital & Harvard Medical School, USA Dr. Daniel Irimia, Massachusetts General Hospital, Boston, USA Prof. Philippa Hulley, NDORMS, University of Oxford News Isolated white blood cell packages from patients with rheumatoid arthritis shown to be protective against inflammationQueen Mary University of London, November 2018 How microvesicles could revolutionise arthritis treatment, The Conversation, November 2015 Injection to end pain of arthritis: New Treatment will stop agony without side-effects, Express, November 2015 Back to top